Trojan Horse Therapy: Scientists Engineer Virus to Make Tumors Self-Destruct

Groundbreaking research from the University of Zurich has unveiled a revolutionary cancer therapy that uses a modified virus to effectively turn tumors against themselves. This innovative approach, described by UZH News, involves engineering a common respiratory virus, an adenovirus, to act like a Trojan horse, infiltrating cancer cells and forcing them to produce their own demise.

How SHREAD Works: Turning Tumors into Drug Factories

The new therapy, named SHREAD (SHielded, REtargeted ADenovirus), is a sophisticated method designed to deliver anti-cancer agents directly to the tumor site. The engineered adenovirus carries genes that instruct the cancer cells to produce therapeutic substances such as antibodies, cytokines, and other signaling molecules. Essentially, the tumor itself becomes a "factory" manufacturing its own destruction.

This localized production of therapeutic agents offers significant advantages over traditional treatments like chemotherapy or radiation. By targeting the delivery directly to the tumor, SHREAD aims to minimize damage to healthy tissues and reduce systemic side effects. As lead researcher Sheena Smith explains, "We trick the tumor into eliminating itself through the production of anti-cancer agents by its own cells."

Promising Results in Lab Tests

In laboratory tests, the SHREAD system was used to deliver trastuzumab (Herceptin®), a clinically approved antibody for breast cancer, directly into tumors in mice. The results were highly encouraging:

• Higher Drug Concentration in Tumors: The study observed significantly higher concentrations of the drug within the tumor compared to direct injection methods.

• Minimal Systemic Exposure: Levels of the drug in the bloodstream and other organs remained remarkably low, indicating reduced collateral damage to healthy tissues.

• Visualizing Tumor Destruction: Researchers employed advanced 3D imaging techniques to visualize the antibody's action. They observed that the antibody created pores in the tumor's blood vessels, facilitating the destruction of cancer cells from within.

This pioneering research marks a significant step forward in targeted cancer therapy, offering a new paradigm for treating tumors by leveraging their own cellular machinery against them.

---